Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

20 Modification Notice

Edoxaban Review Service W91017

  • First published: 21 August 2026
  • Last modified: 21 August 2026
  • Version: N/A
  •  

  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Contents

Summary

OCID:
ocds-kuma6s-168377
Published by:
Betsi Cadwaladr University Health Board
Authority ID:
AA88547
Publication date:
21 August 2026
Deadline date:
-
Notice type:
20 Modification Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

Edoxaban Review Service is a service that requires a clinical review of all patients prescribed edoxaban for atrial fibrillation registered with GPs in BCUHB to assess if they are suitable for a more cost effective alternative and then change those that are. Part 1 - Edoxaban Patient Review Clinical review of the records of patients prescribed edoxaban. Those deemed suitable for a switch proceed to a consultation with the patient or their representative. Consultations to switch edoxaban to generic apixaban or generic rivaroxaban can be done via telephone, virtually or face-to-face. Part 2 - Edoxaban Patient Review that results in a switch to generic apixaban or generic rivaroxaban If clinically appropriate and the patient agrees to the switch to either generic rivaroxaban or generic apixaban; prescribe as indicated. Provider is Pendre Surgery Clayton Road, Mold, CH7 1SS CPV: 85121100, 85121100.

Full notice text

Modification notice

Modification of a contract/concession during its term

Section I: Contracting entity

I.1) Name and addresses

Betsi Cadwaladr University Health Board

Headquarters, Ysbyty Gwynedd, Penrhosgarnedd

Bangor

LL57 2PW

UK

Contact person: Vicky Allum

Telephone: +44 2921501263

E-mail: vicky.allum@wales.nhs.uk

NUTS: UKL

Internet address(es)

Main address: https://bcuhb.nhs.wales/

Address of the buyer profile: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA88547

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Edoxaban Review Service W91017

Reference number: BCU-MSP02-Edoxaban-W91017

II.1.2) Main CPV code

85121100

 

II.1.3) Type of contract

Services

II.2) Description

II.2.2) Additional CPV code(s)

85121100

II.2.3) Place of performance

NUTS code:

UKL

UKL23

II.2.4) Description of the procurement

Edoxaban Review Service is a service that requires a clinical review of all patients prescribed edoxaban for atrial fibrillation registered with GPs in BCUHB to assess if they are suitable for a more cost effective alternative and then change those that are.

Part 1 - Edoxaban Patient Review

Clinical review of the records of patients prescribed edoxaban.

Those deemed suitable for a switch proceed to a consultation with the patient or their representative. Consultations to switch edoxaban to generic apixaban or generic rivaroxaban can be done via telephone, virtually or face-to-face.

Part 2 - Edoxaban Patient Review that results in a switch to generic apixaban or generic rivaroxaban

If clinically appropriate and the patient agrees to the switch to either generic rivaroxaban or generic apixaban; prescribe as indicated.

Provider is Pendre Surgery Clayton Road, Mold, CH7 1SS

II.2.7) Duration of the contract, framework agreement, dynamic purchasing system or concession

Start: 03/08/2026

End: 31/01/2027

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure

IV.2) Administrative information

IV.2.1) Previous publication concerning this procedure

Notice number in the OJ S:

2026/S 000-070774

Section V: Award of contract/concession

Contract No: BCU-MSP02-Edoxaban-W91017

Title: Edoxaban Review Service W91017

V.2 Award of contract/concession

V.2.1) Date of conclusion of the contract/concession

04/08/2026

V.2.2) Information about tenders

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor/concessionaire

Pendre Surgery

Pendre Surgery, Clayton Road

Mold

CH7 1SS

UK

Telephone: +44 1352744381

NUTS: UK

The contractor/concessionaire is an SME: Yes

V.2.4) Information on value of the contract/lot/concession (excluding VAT)

Total value of the contract/lot: /concession: 6 180.00  GBP

Section VI: Complementary information

VI.3) Additional information

This is a Provider Selection Regime Wales (PSR Wales) confirmation of contract award notice. The awarding of this contract is subject to the Health Services (Provider Selection Regime) (Wales) Regulations 2025. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015/Procurement Act 2023 do not apply to this award. The publication of this notice marks the award to a provider under the Most Suitable Provider Process, this notice serves as an award of contract under the PSR Wales.

Contract awarded is Edoxaban Review Service 3rd August 2026 to 31st January 2027.

The decision makers were the Associate Director Primary Care, Medical Director Primary Care, Head of Pharmacy Primary Care, Primary Care Contracts Manager and Clinical Governance Managers. There are no noted conflict of interests. No providers were excluded.

(WA Ref:169495)

VI.4) Procedures for review

VI.4.1) Review body

High Court

Royal Courts of Justice, The Strand

London

WC2A 2LL

UK

Telephone: +44 2079477501

VI.5) Date of dispatch of this notice

21/08/2026

Section VII: Modifications to the contract/concession

VII.1) Description of the procurement after the modifications

VII.1.1) Main CPV code

85121100

 

VII.1.2) Additional CPV code(s)

VII.1.3) Place of performance

NUTS code:

UKL23

VII.1.4) Description of the procurement

Most Suitable Provider Process confirmation of contract award notice, for the avoidance of doubt, this notice does not represent a modification of contract.

VII.1.5) Duration of the contract, framework agreement, dynamic purchasing system or concession

Start: 03/08/2026

End: 31/01/2027

VII.1.6) Information on value of the contract/lot/concession (excluding VAT)

Total value of the procurement: 6 180.00 GBP

The contract/concession has been awarded to a group of economic operators: No

VII.1.7) Name and address of the contractor/concessionaire

Pendre Surgery

Pendre Surgery, Clayton Road

Mold

CH7 1SS

UK

Telephone: +44 1352744381

NUTS: UK

The contractor/concessionaire is an SME: Yes

VII.2) Information about modifications

VII.2.1) Description of the modifications

This is a Provider Selection Regime Wales (PSR Wales) confirmation of contract award notice. This contract has been awarded under the Health Services (Provider Selection Regime) (Wales) Regulations 2025. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015/Procurement Act 2023 do not apply to this award. This contract has now been formally awarded using the Most Suitable Provider Process.

VII.2.2) Reasons for modification

Need for additional works, services or supplies by the original contractor/concessionaire

Description of the economic or technical reasons and the inconvenience or duplication of cost preventing a change of contractor:

Most Suitable Provider Process confirmation of contract award notice, for the avoidance of doubt, this notice does not represent a modification of contract.

VII.2.3) Increase in price

Updated total contract value before the modifications (taking into account possible earlier contract modifications and price adaptions and, in the case of Directive 2014/23/EU, average inflation in the Member State concerned)

Value excluding VAT: 6 180.00 Currency: GBP

Total contract value after the modifications

Value excluding VAT: 6 180.00 Currency: GBP

Coding

Commodity categories

ID Title Parent category
85121100 General-practitioner services Medical practice services

Delivery locations

ID Description
1023 Flintshire and Wrexham

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

Document family

Notice details
Publication date:
27 July 2026
Notice type:
03 Contract Award Notice - Successful Supplier(s)
Authority name:
Betsi Cadwaladr University Health Board
Publication date:
21 August 2026
Notice type:
20 Modification Notice
Authority name:
Betsi Cadwaladr University Health Board

About the buyer

Main contact:
vicky.allum@wales.nhs.uk
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.